Biopolar
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- Undisclosed
Investors
- 2
About Biopolar
Established in 2018 and based in Nantong, China, Biopolar is a pharmaceutical technology company that focuses on the development of small molecule drugs for the treatment of hematological tumors and immune diseases. The company has a research and development team of nearly 40 employees. The company engages in the development of small molecule drugs for the treatment of hematological tumors and immune diseases. Its main products include BPHY-01, BPHY-02 and BPHY-03 etc. It also has a preclinical drug development platform.
Who invested in Biopolar
2 investors across 1 round
See all investors in Biopolar
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 14, 2021
Amount
Undisclosed
Investors
Questions about Biopolar
Who invested in Biopolar?
Biopolar has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biopolar raised?
Biopolar has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Biopolar last raise money?
Biopolar's most recent round on record is a Series A, in Oct 2021.
What does Biopolar do?
Established in 2018 and based in Nantong, China, Biopolar is a pharmaceutical technology company that focuses on the development of small molecule drugs for the treatment of hematological tumors and immune diseases.
Where is Biopolar headquartered?
Biopolar is headquartered in Nantong, China.
Which VCs invest in companies like Biopolar?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Biopolar's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Biopolar? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.